医美界最大忽悠，栽了！

Core Viewpoint - The article discusses the fraudulent activities of Jiangsu Wuzhong (ST Suwu), a company that has been involved in long-term deception and asset stripping, leading to its forced delisting from the stock market due to severe violations of regulations [3][17]. Group 1: Company Background and Fraudulent Activities - Jiangsu Wuzhong has a history of "cross-era fraud," where different controlling parties engaged in deceptive practices over time, ultimately leading to significant financial losses for investors [5]. - The company was initially involved in the textile industry and later attempted various transformations, including real estate and chemical sectors, before venturing into the medical aesthetics industry [7]. - The company gained notoriety for its medical aesthetics product, AestheFill, which became popular but was later undermined by legal disputes with its supplier, Regen [12]. Group 2: Key Events Leading to Delisting - Jiangsu Wuzhong's stock experienced a misleading surge, with five consecutive days of trading at the upper limit before being suspended, creating a false impression of success [16]. - Regulatory investigations revealed multiple instances of fraud, including the misrepresentation of controlling shareholders and the inflation of revenue and profits, with related party transactions amounting to 1.693 billion yuan, which constituted 96.09% of the company's net assets [17]. - The company and its controlling shareholders faced severe penalties, including a 15 million yuan fine for the actual controller, Qian Qunshan, and a ten-year ban from the securities market [18]. Group 3: Legal and Financial Consequences - Jiangsu Wuzhong and its subsidiaries have been labeled with negative legal tags, and the ongoing legal disputes with Regen have led to a significant claim of 1.6 billion yuan for damages [19]. - The article highlights the broader implications of the case, noting that the surge in the capital market has led to increased scrutiny and regulatory actions against companies engaging in fraudulent activities, with a record number of 13 companies facing delisting measures in 2025 [18].